DNA Damage and Activated Caspase-3 Expression in Neurons and Astrocytes: Evidence for Apoptosis in Frontotemporal Dementia

Frontotemporal dementia (FTD) is a neurodegenerative disease which affects mainly the frontal and anterior temporal cortex. It is associated with neuronal loss, gliosis, and microvacuolation of lamina I to III in these brain regions. In previous studies we have described neurons with DNA damage in the absence of tangle formation and suggested this may result in tangle-independent mechanisms of neurodegeneration in the AD brain. In the present study, we sought to examine DNA fragmentation and activated caspase-3 expression in FTD brain where tangle formation is largely absent. The results demonstrate that numerous nuclei were TdT positive in all FTD brains examined. Activated caspase-3 immunoreactivity was detected in both neurons and astrocytes and was elevated in FTD cases as compared to control cases. A subset of activated caspase-3-positive cells were also TdT positive. In addition, the cell bodies of a subset of astrocytes showed enlarged, irregular shapes, and vacuolation and their processes appeared fragmented. These degenerating astrocytes were positive for activated caspase-3 and colocalized with robust TdT-labeled nuclei. These findings suggest that a subset of astrocytes exhibit degeneration and that DNA damage and activated caspase-3 may contribute to neuronal cell death and astrocyte degeneration in the FTD brain. Our results suggest that apoptosis may be a mechanism of neuronal cell death in FTD as well as in AD (228).

[1]  K. Jellinger,et al.  Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. , 1999, The American journal of pathology.

[2]  David Smith,et al.  Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation , 1999, Cell.

[3]  K. Roth,et al.  In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system , 1998, Cell Death and Differentiation.

[4]  Y. Uchiyama,et al.  Detection of activated Caspase-3 by a cleavage site-directed antiserum during naturally occurring DRG neurons apoptosis. , 1998, Biochemical and biophysical research communications.

[5]  M. Moskowitz,et al.  Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia , 1998, The Journal of Neuroscience.

[6]  S. Nagata,et al.  Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis , 1998, Nature.

[7]  J. Kimura,et al.  Regressive changes of astroglia in white matter lesions in cerebrovascular disease and Alzheimer’s disease patients , 1997, Acta Neuropathologica.

[8]  Xiaodong Wang,et al.  DFF, a Heterodimeric Protein That Functions Downstream of Caspase-3 to Trigger DNA Fragmentation during Apoptosis , 1997, Cell.

[9]  R. Gascoyne,et al.  Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. , 1997, Cancer research.

[10]  J. Tschopp,et al.  Direct physical interaction between the Caenorhabditis elegans ‘death proteins’ CED‐3 and CED‐4 , 1997, FEBS letters.

[11]  Dean P. Jones,et al.  Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.

[12]  A. Chinnaiyan,et al.  Interaction of CED-4 with CED-3 and CED-9: A Molecular Framework for Cell Death , 1997, Science.

[13]  D. Green,et al.  The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.

[14]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[15]  Emad S. Alnemri,et al.  Activation of a CrmA-insensitive, p35-sensitive Pathway in Ionizing Radiation-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[16]  C. Cotman,et al.  Bax Protein Expression Is Increased in Alzheimer's Brain: Correlations with DNA Damage, Bcl‐2 Expression, and Brain Pathology , 1997, Journal of neuropathology and experimental neurology.

[17]  Junying Yuan,et al.  Human ICE/CED-3 Protease Nomenclature , 1996, Cell.

[18]  T. Ley,et al.  Cleavage of CPP32 by Granzyme B Represents a Critical Role for Granzyme B in the Induction of Target Cell DNA Fragmentation* , 1996, The Journal of Biological Chemistry.

[19]  Xiaodong Wang,et al.  Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.

[20]  R. Pearce,et al.  Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Raff,et al.  Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death , 1996, The Journal of cell biology.

[22]  S. Nagata,et al.  Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis , 1996, Nature.

[23]  G. Gores,et al.  The role of proteases during apoptosis , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  C. Cotman,et al.  DNA damage and apoptosis in Alzheimer's disease: colocalization with c- Jun immunoreactivity, relationship to brain area, and effect of postmortem delay , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[25]  C. Cotman,et al.  Up‐regulation of Bcl‐2 is associated with neuronal DNA damage in Alzheimer's disease , 1996, NeuroReport.

[26]  M. Lavin,et al.  The ICE family of cysteine proteases as effectors of cell death. , 1996, Cell death and differentiation.

[27]  C. Duyckaerts,et al.  The neuropathologic diagnostic criteria of frontal lobe dementia revisited. A study of ten consecutive cases. , 1996, Journal of neural transmission. Supplementum.

[28]  E. Alnemri,et al.  Mch3, a novel human apoptotic cysteine protease highly related to CPP32. , 1995, Cancer research.

[29]  M. van Lookeren Campagne,et al.  Microwave-enhanced in situ end-labeling of fragmented DNA: parametric studies in relation to postmortem delay and fixation of rat and human brain. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[30]  Patrick R. Griffin,et al.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis , 1995, Nature.

[31]  Brian J Cummings,et al.  Immunohistochemical evidence for apoptosis in Alzheimer's disease. , 1994, Neuroreport.

[32]  L. Wang,et al.  Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death , 1994, Cell.

[33]  M. Satoh,et al.  Enzymatic repair of oxidative DNA damage. , 1994, Cancer research.

[34]  Brian J Cummings,et al.  Subpopulations of dystrophic neuritis in Alzheimer's brain with distinct immunocytochemical and argentophilic characteristics , 1994, Brain Research.

[35]  M. Nieto‐Sampedro,et al.  Active microglia, sick astroglia and Alzheimer type dementias. , 1994, Neuroreport.

[36]  D. Mann,et al.  Frontal lobe dementia is not a variant of prion disease , 1993, Neuroscience Letters.

[37]  Shai Shaham,et al.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme , 1993, Cell.

[38]  Carl W. Cotman,et al.  Identification and distribution of axonal dystrophic neurites in Alzheimer's disease , 1993, Brain Research.

[39]  H. Lassmann,et al.  Detection of DNA fragmentation in apoptosis: application of in situ nick translation to cell culture systems and tissue sections. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[40]  John Q. Trojanowski,et al.  Abnormal tau phosphorylation at Ser396 in alzheimer's disease recapitulates development and contributes to reduced microtubule binding , 1993, Neuron.

[41]  D. Neary,et al.  Dementia of frontal lobe type: neuropathology and immunohistochemistry. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[42]  A. Brun.  Frontal lobe degeneration of non-Alzheimer type revisited. , 1993, Dementia.

[43]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[44]  E. Mandelkow,et al.  The switch of tau protein to an Alzheimer‐like state includes the phosphorylation of two serine‐proline motifs upstream of the microtubule binding region. , 1992, The EMBO journal.

[45]  B. L. Miller,et al.  Frontal lobe degeneration , 1991, Neurology.

[46]  O. Steward,et al.  The process of reinnervation in the dentate gyrus of adult rats: time course of increases in mRNA for glial fibrillary acidic protein , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[47]  D. Neary,et al.  Dementia of frontal lobe type. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[48]  A Brun,et al.  Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. , 1987, Archives of gerontology and geriatrics.

[49]  L. Gustafson,et al.  Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. , 1987, Archives of gerontology and geriatrics.